A MODEL FOR PRIMITIVE NEUROECTODERMAL TUMORS IN TRANSGENIC NEURAL TRANSPLANTS HARBORING THE SV40 LARGE T-ANTIGEN

被引:0
|
作者
EIBL, RH
KLEIHUES, P
JAT, PS
WIESTLER, OD
机构
[1] UNIV BONN,MED CTR,DEPT NEUROPATHOL,BONN,GERMANY
[2] UNIV ZURICH,DEPT PATHOL NEUROPATHOL,ZURICH,SWITZERLAND
[3] LUDWIG INST CANC RES,LONDON,ENGLAND
来源
AMERICAN JOURNAL OF PATHOLOGY | 1994年 / 144卷 / 03期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Using retrovirus-mediated transfer of the SV40 virus large T antigen into neural transplants, we have observed a high incidence of primitive neuroectodermal tumors (PNET). These neoplasms developed in 8 of 14 (57%) neural grafts after latency periods of 176 to 311 days. Histopathologically, the tumors exhibited features of human PNET such as formation of neuroblastic rosettes and immunocytochemical evidence for neuronal differentiation, synaptogenesis, and focal astrocytic differentiation. All neoplasms showed a striking migratory potential. The presence of the large T gene in the tumors was demonstrated by polymerase chain reaction-mediated amplification of a specific 242 bp segment of large T and DNA sequence analysis. Large T antigen was identified in tissue sections using an immunocytochemical reaction with the monoclonal antibody Pab 108. Cell lines were established from several tumors and subjected to G418 selection. Secondary tumors induced fly intracerebral transplantation of these cells retained the characteristic morphological and immunocytochemical propel-ties of PNETs. These experiments demonstrate a considerable transforming potential of SV40 large T antigen for neural precursor cells. The long latency Period suggests that neoplastic transformation initiated by the large T gene requires additional spontaneous mutations of cooperating cellular genes. Because the mechanism of transformation by large T antigen appears to involve complex formation with and inactivation of cellular tumor suppressor gene products, these cell lines may serve as an interesting tool to search for novel neural tumor suppressor genes.
引用
收藏
页码:556 / 564
页数:9
相关论文
共 50 条
  • [1] SV40 TRANSGENIC MICE THAT DEVELOP TUMORS ARE IMMUNOLOGICALLY TOLERANT TO SV40 T-ANTIGEN
    FAAS, SJ
    PAN, S
    PINKERT, CA
    BRINSTER, RL
    KNOWLES, BB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 56 - 56
  • [2] SV40 T-ANTIGEN ACTS AS A MINOR HISTOCOMPATIBILITY ANTIGEN OF SV40 T-ANTIGEN TOLERANT TRANSGENIC MICE
    JURETIC, A
    KNOWLES, BB
    IMMUNOGENETICS, 1989, 29 (06) : 366 - 370
  • [3] TRANSGENIC MICE HARBORING SV40 T-ANTIGEN GENES DEVELOP CHARACTERISTIC BRAIN-TUMORS
    BRINSTER, RL
    CHEN, HY
    MESSING, A
    VANDYKE, T
    LEVINE, AJ
    PALMITER, RD
    CELL, 1984, 37 (02) : 367 - 379
  • [4] PHOSPHORYLATION OF SV40 LARGE T-ANTIGEN
    SCHEIDTMANN, KH
    BIRGIT, E
    WALTER, G
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1982, 253 (01): : 35 - 35
  • [5] IS SV40 LARGE T-ANTIGEN AN ENZYME
    HAND, R
    STEDMAN, D
    ISMAIL, A
    BAUMANN, E
    CLINICAL RESEARCH, 1981, 29 (02): : A548 - A548
  • [6] PHOSPHORYLATION OF SV40 LARGE T-ANTIGEN
    WALTER, G
    FLORY, PJ
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1979, 44 : 165 - 169
  • [7] SV40 T-ANTIGEN IS A HISTOCOMPATIBILITY ANTIGEN OF SV40-TRANSGENIC MICE
    WETTSTEIN, PJ
    JEWETT, L
    FAAS, S
    BRINSTER, RL
    KNOWLES, BB
    IMMUNOGENETICS, 1988, 27 (06) : 436 - 441
  • [8] PHOSPHORYLATION OF SV40 LARGE T-ANTIGEN IN SV40 NUCLEOPROTEIN COMPLEXES
    MANN, K
    HUNTER, T
    VIROLOGY, 1980, 107 (02) : 526 - 532
  • [9] SV40 SMALL T-ANTIGEN ENHANCES THE TRANSFORMATION ACTIVITY OF LIMITING CONCENTRATIONS OF SV40 LARGE T-ANTIGEN
    BIKEL, I
    MONTANO, X
    AGHA, ME
    BROWN, M
    MCCORMACK, M
    BOLTAX, J
    LIVINGSTON, DM
    CELL, 1987, 48 (02) : 321 - 330
  • [10] SIMIAN VIRUS-40 (SV40)-TRANSGENIC MICE THAT DEVELOP TUMORS ARE SPECIFICALLY TOLERANT TO SV40 T-ANTIGEN
    FAAS, SJ
    PAN, S
    PINKERT, CA
    BRINSTER, RL
    KNOWLES, BB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02): : 417 - 427